`Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations
`Start Over6 | Back to Search Page
`Applicant Holder Search Results from "OB_Rx" table for query on "Coastal."
`Displaying records 1 to 16 of 16
`
`Download data
`
`Appl
`No
`
`RLD8
`
`TE
`Code7
`
`Active
`Ingredient
`
`A090177
`
`AA
`
`A090177
`
`AA
`
`A090177
`
`AA
`
`A090177
`
`AA
`
`A091670
`
`AA
`
`No
`
`No
`
`No
`
`No
`
`No
`
`ACETAMINOPHEN;
`OXYCODONE
`HYDROCHLORIDE
`ACETAMINOPHEN;
`OXYCODONE
`HYDROCHLORIDE
`ACETAMINOPHEN;
`OXYCODONE
`HYDROCHLORIDE
`ACETAMINOPHEN;
`OXYCODONE
`HYDROCHLORIDE
`ASPIRIN;
`OXYCODONE
`HYDROCHLORIDE
`BROMFENAC
`SODIUM
`LIOTHYRONINE
`SODIUM
`LIOTHYRONINE
`SODIUM
`LIOTHYRONINE
`SODIUM
`No METHAMPHETAMINE
`HYDROCHLORIDE
`Yes NYSTATIN
`
`A201211
`
`AT1 No
`
`No
`
`No
`
`No
`
`A090097
`
`AB
`
`A090097
`
`AB
`
`A090097
`
`AB
`
`A091189
`
`AA
`
`A065203
`
`AT
`
`A203107
`
`AB
`
`No
`
`A204092
`
`AA
`
`No
`
`A091313
`
`AB
`
`No
`
`A091313
`
`AB
`
`No
`
`A091313
`
`AB
`
`No
`
`OXYCODONE
`HYDROCHLORIDE
`OXYCODONE
`HYDROCHLORIDE
`OXYCODONE
`HYDROCHLORIDE
`OXYCODONE
`HYDROCHLORIDE
`OXYCODONE
`HYDROCHLORIDE
`
`Dosage
`Form;
`Route
`TABLET; ORAL
`
`Strength
`
`325MG; 10MG
`
`TABLET; ORAL
`
`325MG; 2.5MG
`
`TABLET; ORAL
`
`325MG; 5MG
`
`TABLET; ORAL
`
`325MG; 7.5MG
`
`TABLET; ORAL
`
`325MG; 4.8355MG
`
`SOLUTION/DROPS;
`OPHTHALMIC
`TABLET; ORAL
`
`EQ 0.09% ACID
`
`EQ 0.005MG BASE
`
`TABLET; ORAL
`
`EQ 0.025MG BASE
`
`TABLET; ORAL
`
`EQ 0.05MG BASE
`
`TABLET; ORAL
`
`5MG
`
`POWDER;
`TOPICAL
`CAPSULE; ORAL
`
`100,000 UNITS/GM
`
`5MG
`
`SOLUTION; ORAL
`
`100MG/5ML
`
`TABLET; ORAL
`
`15MG
`
`TABLET; ORAL
`
`30MG
`
`TABLET; ORAL
`
`5MG
`
`Proprietary
`Name
`
`OXYCODONE
`AND
`ACETAMINOPHEN
`OXYCODONE
`AND
`ACETAMINOPHEN
`OXYCODONE
`AND
`ACETAMINOPHEN
`OXYCODONE
`AND
`ACETAMINOPHEN
`OXYCODONE
`AND ASPIRIN
`
`BROMFENAC
`SODIUM
`LIOTHYRONINE
`SODIUM
`LIOTHYRONINE
`SODIUM
`LIOTHYRONINE
`SODIUM
`METHAMPHETAMINE
`HYDROCHLORIDE
`NYSTATIN
`
`OXYCODONE
`HYDROCHLORIDE
`OXYCODONE
`HYDROCHLORIDE
`OXYCODONE
`HYDROCHLORIDE
`OXYCODONE
`HYDROCHLORIDE
`OXYCODONE
`HYDROCHLORIDE
`
`Applicant
`
`COASTAL
`PHARMS
`
`COASTAL
`PHARMS
`
`COASTAL
`PHARMS
`
`COASTAL
`PHARMS
`
`COASTAL
`PHARMS
`
`COASTAL
`PHARMS
`COASTAL
`PHARMS
`COASTAL
`PHARMS
`COASTAL
`PHARMS
`COASTAL
`PHARMS
`COASTAL
`PHARMS
`COASTAL
`PHARMS
`COASTAL
`PHARMS
`COASTAL
`PHARMS
`COASTAL
`PHARMS
`COASTAL
`PHARMS
`
`Return to Electronic Orange Book Home Page9
`
`FDA/Center for Drug Evaluation and Research
`Office of Generic Drugs
`Division of Labeling and Program Support
`Update Frequency:
`Orange Book Data - Monthly
`Generic Drug Product Information & Patent Information - Daily
`Orange Book Data Updated Through December 2014
`Patent and Generic Drug Product Data Last Updated January 26, 2015
`
`Links on this page:
`1. http://www.addthis.com/bookmark.php?u508=true&v=152&username=fdamain
`
`Page 1 of 2
`
`SENJU EXHIBIT 2023
`METRICS v. SENJU
`IPR2014-01041
`
`
`
`2. http://www.addthis.com/bookmark.php
`3. http://www.fda.gov/default.htm
`4. http://www.fda.gov/Drugs/InformationOnDrugs/default.htm
`5.
`../default.cfm
`6.
`../default.cfm
`7. http://www.fda.gov/Drugs/DevelopmentApprovalProcess/ucm079068.htm#Therapeutic Equivalence-Related Terms
`8. http://www.fda.gov/Drugs/DevelopmentApprovalProcess/ucm079068.htm#Reference Listed Drug
`9.
`../default.cfm
`
`Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
`Accessibility Contact FDA Careers FDA Basics FOIA No Fear Act Site Map Transparency Website Policies
`
`U.S. Food and Drug Administration
`10903 New Hampshire Avenue
`Silver Spring, MD 20993
`Ph. 1-888-INFO-FDA (1-888-463-6332)
`Email FDA
`
`For Government For Press
`Combination Products Advisory Committees Science & Research Regulatory Information Safety Emergency Preparedness International Programs News &
`Events Training and Continuing Education Inspections/Compliance State & Local Officials Consumers Industry Health Professionals FDA Archive
`
`Links on this page:
`
`Page 2 of 2
`
`